Detalhe da pesquisa
1.
Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication.
J Virol
; 97(6): e0037023, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219458
2.
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model.
Int J Mol Sci
; 23(17)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077380
3.
Concepts in Oncolytic Adenovirus Therapy.
Int J Mol Sci
; 22(19)2021 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638863
4.
STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.
Int J Mol Sci
; 21(3)2020 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32046095
5.
YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells.
Front Oncol
; 14: 1304374, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357194
6.
TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model.
Front Immunol
; 15: 1330868, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318175
7.
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.
Mol Oncol
; 18(3): 528-546, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115217
8.
YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.
J Transl Med
; 11: 216, 2013 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24044901
9.
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice.
Cancers (Basel)
; 15(20)2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37894279
10.
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.
Clin Cancer Res
; 29(10): 1996-2011, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892582
11.
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.
Nat Commun
; 13(1): 4689, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948546
12.
Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer.
J Pers Med
; 11(5)2021 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33923231
13.
Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.
Viruses
; 13(8)2021 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452286
14.
Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force.
Mol Pharm
; 7(4): 1069-89, 2010 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20550160
15.
Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer.
J Exp Clin Cancer Res
; 38(1): 322, 2019 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331377
16.
The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer.
Hum Gene Ther
; 30(1): 44-56, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29916265
17.
Impact of radiation therapy on the oncolytic adenovirus dl520: implications on the treatment of glioblastoma.
Radiother Oncol
; 86(3): 419-27, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17967494
18.
Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
Int J Oncol
; 31(2): 419-30, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17611700
19.
Adenovirus Particle Quantification in Cell Lysates Using Light Scattering.
Hum Gene Ther Methods
; 28(5): 268-276, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28806885
20.
Virotherapy Research in Germany: From Engineering to Translation.
Hum Gene Ther
; 28(10): 800-819, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870120